Used in pharmaceutical research as an intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of novel neuroactive agents due to its ability to cross the blood-brain barrier and interact with receptor sites. Employed in studies exploring treatments for psychiatric and neurological conditions, including anxiety, depression, and cognitive disorders. Its oxime functionality allows for further chemical modifications, making it valuable in structure-activity relationship (SAR) studies. Also utilized in the preparation of radiolabeled derivatives for use in positron emission tomography (PET) imaging to investigate brain receptor distribution.